Flock, smart-money disclosures made readable

Theravance Biopharma Inc

TBPHNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDT+30
Weiss Asset Management LP
Theravance Biopharma Inc · NASDAQ
−7,457,060 sh · $126.8M
Filed 28 Sept 2026SEC Form 4view source
REDUCEDT+30
Sawaf Aziz
Theravance Biopharma Inc · NASDAQ
−23,439 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Sawaf Aziz
Theravance Biopharma Inc · NASDAQ
−204,966 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Mitchell Dean J
Theravance Biopharma Inc · NASDAQ
−91,204 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Farnum Rhonda
Theravance Biopharma Inc · NASDAQ
−89,062 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Winningham Rick E
Theravance Biopharma Inc · NASDAQ
−23,400 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Smaldone Alsup Laurie
Theravance Biopharma Inc · NASDAQ
−6,009 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Grimaud Brett A.
Theravance Biopharma Inc · NASDAQ
−23,439 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Gray Susannah
Theravance Biopharma Inc · NASDAQ
−6,009 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Winningham Rick E
Theravance Biopharma Inc · NASDAQ
−151,875 sh
Filed 24 Sept 2026SEC Form 4view source

Announcements

No announcements on record for this security.

Show all 37 disclosures

REDUCEDT+30
Gray Susannah
Theravance Biopharma Inc · NASDAQ
−42,137 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Winningham Rick E
Theravance Biopharma Inc · NASDAQ
−92,567 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
O'Connor Donal
Theravance Biopharma Inc · NASDAQ
−6,009 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Smaldone Alsup Laurie
Theravance Biopharma Inc · NASDAQ
−74,980 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Farnum Rhonda
Theravance Biopharma Inc · NASDAQ
−124,414 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Pakianathan Deepika
Theravance Biopharma Inc · NASDAQ
−6,009 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
O'Connor Donal
Theravance Biopharma Inc · NASDAQ
−74,204 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Grimaud Brett A.
Theravance Biopharma Inc · NASDAQ
−107,812 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Pakianathan Deepika
Theravance Biopharma Inc · NASDAQ
−58,065 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Sawaf Aziz
Theravance Biopharma Inc · NASDAQ
−108,436 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Winningham Rick E
Theravance Biopharma Inc · NASDAQ
−76,875 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Miller Aine
Theravance Biopharma Inc · NASDAQ
−96,718 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Mitchell Dean J
Theravance Biopharma Inc · NASDAQ
−6,009 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Miller Aine
Theravance Biopharma Inc · NASDAQ
−93,108 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Grimaud Brett A.
Theravance Biopharma Inc · NASDAQ
−223,917 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Winningham Rick E
Theravance Biopharma Inc · NASDAQ
−1,382,272 sh
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Farnum Rhonda
Theravance Biopharma Inc · NASDAQ
−3,329 sh · $56.7K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDT+30
Farnum Rhonda
Theravance Biopharma Inc · NASDAQ
−3,328 sh · $56.7K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDT+30
Farnum Rhonda
Theravance Biopharma Inc · NASDAQ
−6,657 sh · $113.4K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDStale
Grimaud Brett A.
Theravance Biopharma Inc · NASDAQ
−7,952 sh · $134.8K
Filed 24 Aug 2026SEC Form 4view source
REDUCEDStale
Miller Aine
Theravance Biopharma Inc · NASDAQ
−6,258 sh · $106.1K
Filed 24 Aug 2026SEC Form 4view source
REDUCEDStale
Farnum Rhonda
Theravance Biopharma Inc · NASDAQ
−5,667 sh · $96.1K
Filed 24 Aug 2026SEC Form 4view source
REDUCEDStale
Winningham Rick E
Theravance Biopharma Inc · NASDAQ
−20,034 sh · $339.6K
Filed 24 Aug 2026SEC Form 4view source
REDUCEDStale
Sawaf Aziz
Theravance Biopharma Inc · NASDAQ
−8,112 sh · $137.5K
Filed 24 Aug 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Theravance Biopharma Inc · NASDAQ
1,258,497 sh · $20.4M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Theravance Biopharma Inc · NASDAQ
127,916 sh · $2.1M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Theravance Biopharma Inc · NASDAQ
3,780,160 sh · $32.1M
Filed 30 Jun 2024SEC 13Fview source